Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Texas Southwestern Medical Center
Age
16–45
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Within 5 years of diagnosis of type 1 diabetes
Between the ages of 16 to 45 years
Have at least one diabetes-related autoantibody present
Have mean C-peptide level \> 0.2 nmol/L on a mixed meal tolerance test
Be taking insulin
Complete written informed consent
You may not be if
Taking inhaled or oral steroids (for example Advair, Orapred)
Have an active infection
Have serologic evidence of HIV, Hepatitis C, Hepatitis C, or tuberculosis
Have ongoing use of medications known to affect glucose tolerance
Have a live vaccine 90 days prior to, or during this study
Taking any other experimental medication within the past 28 days
Have prior treatment with rilonacept
Have any complicating medical issues or abnormal clinical laboratory blood counts or results that interfere with study conduct; history of malignancies
Pregnant or lactating females
Males and females unwilling to use an acceptable method of contraception for the duration of the study
